• Japanese
  • Korean
  • Chinese
Cover Image

Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY

“2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY” is a comprehensive, total market intelligence solution designed for senior executives who are looking for:

  • High quality, granular, deeply segmented data
  • Access to senior LSI analysts to conduct proprietary modeling and custom market simulations
  • Access to useable source data for in-house customization and adoption of market models

This product is a complete market intelligence solution.

The deliverables include:

  • Initial report with most recent data available (PDF and Excel)
  • Extensive access to senior LSI analyst for proprietary add-on analysis
  • Online platform making the data useable and interactive

Table of Contents

1. ESTABLISHED AND EMERGING TECHNOLOGIES

  • 1.1. Features of Established Technologies
  • 1.2. Challenges for Established Technologies
    • 1.2.1. Conformality
    • 1.2.2. Anoxic Tissues
      • 1.2.2.1. Economic Factors
        • 1.2.2.1.1. Reimbursement and National Policies and Initiatives
        • 1.2.2.1.2. System Prices & Associated Costs
        • 1.2.2.1.3. The Global Economy
  • Exhibit 1-1: External Radiation Therapy by Type
  • Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
  • Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
  • Exhibit 1-4: Features of Particle Therapy Centers
  • Exhibit 1-5: Challenges Associated with Available Technologies
  • Exhibit 1-6: Established and Emerging Technologies

2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators & Gamma-Ray Systems, 2007-2013
  • Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
  • Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
  • Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear Accelerators, 2007-2013
  • Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by Application, 2007-2013
  • Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
  • Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
  • Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type, 2007-2013
  • Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type, 2007-2013
  • Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type, 2007-2013
  • Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure, 2007-2013
  • Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems, 2007-2013.
  • Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
  • Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External Radiation Therapy in the U.S., 2007-2013
  • Exhibit 2-24: Other Patients Treated with External Radiation Therapy, 2007-2013
  • Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S., 2007-2013
  • Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy, 2007-2013
  • Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
  • Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
  • Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013

3. OUS MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 3-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
  • Exhibit 3-2: OUS External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 3-3: Factors Influencing the OUS Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 3-4: External Radiation Therapy in Europe, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-5: Linear Accelerator & Gamma-Ray Systems, European Shares in 2008
  • Exhibit 3-6: European Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 3-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 & 2013
  • Exhibit 3-8: AP & ROW External Radiation Therapy, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
  • Exhibit 3-10: AP & ROW Market Forecast by Type of System, Gamma-Ray & Linear Accelerator Systems, 2007-2013
  • Exhibit 3-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
  • Exhibit 3-12: Factors Influencing the OUS Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 3-13: External Radiation Therapy, European Market Forecast by Application, 2007-2013
  • Exhibit 3-14: SRS and External Radiation Systems in Europe, 2008 & 2013
  • Exhibit 3-15: Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-16: Stereotactic Radiosurgery - European Patient Volumes by Type, 2007-2013
  • Exhibit 3-17: Stereotactic Radiosurgery - Utilization by Patient Type in Europe, 2007-2013
  • Exhibit 3-18: Extracranial Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-19: Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-20: Stereotactic Radiosurgery - European Procedures by Type, 2007-2013
  • Exhibit 3-21: Stereotactic Radiosurgery in Europe - Utilization by Procedure, 2007-2013
  • Exhibit 3-22: Extracranial Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-23: Breast, Lung and Prostate Patients Treated with Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-24: Other Patients Treated with External Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-25: External Radiation Therapy in Europe, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-26: Other External Radiation Therapy Procedures in Europe, 2007-2013
  • Exhibit 3-27: External Radiation Therapy, AP & ROW Market Forecast by Application, 2007-2013
  • Exhibit 3-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes, 2007-2013
  • Exhibit 3-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by Type, 2007-2013
  • Exhibit 3-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of Patients, 2007-2013
  • Exhibit 3-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes, 2007-2013
  • Exhibit 3-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type, 2007-2013
  • Exhibit 3-33: Breast, Lung and Prostate Patients Treated with Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-34: Other Patients Treated with External Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-35: External Radiation Therapy in AP & ROW Countries, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-36: Other External Radiation Therapy Procedures in AP & ROW Countries, 2007-2013
  • Exhibit 3-37: Factors Influencing the OUS Market for Particle Therapy, 2007-2013
  • Exhibit 3-38: Particle Therapy, European Market Forecast, 2007-2013
  • Exhibit 3-39: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-40: Particle Therapy Systems, European Supplier Shares in 2008
  • Exhibit 3-41: Particle Therapy, European Patient Volumes, 2007-2013
  • Exhibit 3-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
  • Exhibit 3-43: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
  • Exhibit 3-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013

4. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

5. EMERGING COMPANIES

Show More
RELATED REPORTS
* Global Radiation Therapy Equipment Market 2014-2018
  • Published:
  • Mar 07, 2014
  • USD 2500
  • 81 Pages

* Global Radiation Therapy Market Report: 2013 Edition
  • Published:
  • Jan 15, 2014
  • USD 800
  • 61 Pages

* Radiation Therapy Equipment
  • Published:
  • Nov 01, 2013
  • USD 4950
  • 336 Pages

* Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017
  • Published:
  • May 31, 2013
  • USD 4650
  • 313 Pages

* North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017
  • Published:
  • Apr 18, 2013
  • USD 4650
  • 282 Pages

* European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Trends & Forecast to 2017
  • Published:
  • Apr 08, 2013
  • USD 4650
  • 303 Pages

* Nuclear Medicine/Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017
  • Published:
  • Apr 03, 2013
  • USD 4650
  • 360 Pages

* Radiation Therapy Devices - Global Opportunity Assessment and Market Forecast to 2018
  • Published:
  • Jul 02, 2012
  • USD 3995
  • 89 Pages

* Market Agent: 2011 O.U.S. MARKETS FOR EXTERNAL RADIATION THERAPY
  • Published:
  • May 01, 2011
  • USD 3900

* Market Agent: 2011 U.S. MARKETS FOR EXTERNAL RADIATION THERAPY
  • Published:
  • May 01, 2011
  • USD 3900

Browse more Nuclear Medical Market Research Reports

Pricing
Get Notified
Email me when related reports are published